Showing 441 - 460 results of 105,224 for search '(( 1 wt decrease ) OR ( 5 ((((non decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.58s Refine Results
  1. 441

    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…In the non-recurrence group, CRT improved from 482.5 ± 112.8 to 294.7 ± 65.3, 302.0 ± 68.0, 284.7 ± 55.4, 285.3 ± 70.2, 265.2 ± 65.0, and 266.1 ± 78.2 μm at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g006" target="_blank">Fig 6</a>).…”
  2. 442
  3. 443
  4. 444
  5. 445
  6. 446
  7. 447

    Decreased GH storage and secretion in PICK1-deficient mice. by Birgitte Holst (250548)

    Published 2013
    “…<p>(A) The livers of PICK-1-deficient mice had a significantly lower weight than those of WT mice (**<i>p</i><0.01). …”
  8. 448
  9. 449
  10. 450
  11. 451
  12. 452

    The decrease of <i>secY2</i> resulted in the inhibition of extracellular protein secretion in <i>Δrnc</i> at 1.5 h. by Yu Liu (6938)

    Published 2013
    “…</i></b> The mRNA levels of <i>secA1, secY1</i>,<i>secA2</i> and <i>secY2</i> were detected at 1.5 h by qRT-PCR. …”
  13. 453

    TRIM5 restriction of HIV-1 has decreased during evolution leading to humans. by Michael Emerman (12304)

    Published 2013
    “…Original data is found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1000301#pbio.1000301-Goldschmidt1" target="_blank">[30]</a> and shows that the antiviral gene TRIM5 restricted HIV-1 better at points in evolution earlier than the chimp–human common ancestor than it does after that. …”
  14. 454
  15. 455
  16. 456

    Efficacy of an herbal compound in decreasing steatosis and transaminase activities in non-alcoholic fatty liver disease: A randomized clinical trial by Seyyed Abbas Zojaji (5208589)

    Published 2022
    “…<div><p>Abstract Hepatoprotective effects of many herbal agents have been reported in animal studies and clinical trials. In this study, five hepatoprotective plants with potent antioxidant, anti-inflammatory, and hypolipidemic effects were chosen to prepare a polyherbal compound for managing NAFLD. …”
  17. 457
  18. 458
  19. 459
  20. 460